BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 15147952)

  • 1. Transcriptional repressor functions of Drosophila E2F1 and E2F2 cooperate to inhibit genomic DNA synthesis in ovarian follicle cells.
    Cayirlioglu P; Ward WO; Silver Key SC; Duronio RJ
    Mol Cell Biol; 2003 Mar; 23(6):2123-34. PubMed ID: 12612083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss.
    Li FX; Zhu JW; Tessem JS; Beilke J; Varella-Garcia M; Jensen J; Hogan CJ; DeGregori J
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12935-40. PubMed ID: 14566047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.
    Wang D; Xu Q; Yuan Q; Jia M; Niu H; Liu X; Zhang J; Young CY; Yuan H
    Oncogene; 2019 May; 38(18):3458-3474. PubMed ID: 30647455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma.
    Wittenburg LA; Ptitsyn AA; Thamm DH
    J Cell Biochem; 2012 Mar; 113(3):773-83. PubMed ID: 21976144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC/C(Cdc20) targets E2F1 for degradation in prometaphase.
    Peart MJ; Poyurovsky MV; Kass EM; Urist M; Verschuren EW; Summers MK; Jackson PK; Prives C
    Cell Cycle; 2010 Oct; 9(19):3956-64. PubMed ID: 20948288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.
    Middeldorp J; Kamphuis W; Sluijs JA; Achoui D; Leenaars CH; Feenstra MG; van Tijn P; Fischer DF; Berkers C; Ovaa H; Quinlan RA; Hol EM
    FASEB J; 2009 Aug; 23(8):2710-26. PubMed ID: 19332645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.
    Gammoh N; Gardiol D; Massimi P; Banks L
    J Virol; 2009 Feb; 83(3):1538-43. PubMed ID: 19004934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional repression of E2F gene by proteasome inhibitors in human osteosarcoma cells.
    Lim JH; Chang YC; Park YB; Park JW; Kwon TK
    Biochem Biophys Res Commun; 2004 Jun; 318(4):868-72. PubMed ID: 15147952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin.
    Magae J; Illenye S; Tejima T; Chang YC; Mitsui Y; Tanaka K; Omura S; Heintz NH
    Oncogene; 1997 Aug; 15(7):759-69. PubMed ID: 9266962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation.
    Hsueh CT; Wu YC; Schwartz GK
    Clin Cancer Res; 2001 Mar; 7(3):669-74. PubMed ID: 11297263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J; Sampath A; Raychaudhuri P; Bagchi S
    Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
    Campanero MR; Flemington EK
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.